OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS
BinaxNOW TAKING COVID-19 TESTING TO A NEW LEVEL BinaxNOW TAKING COVID-19 TESTING TO A NEW LEVEL BinaxNOW TAKING COVID-19 TESTING TO A NEW LEVEL BinaxNOW TAKING COVID-19 TESTING TO A NEW LEVEL

NO MORE BARRIERS. NO MORE INCONVENIENCES. ANSWERS, WHEN AND WHERE YOU NEED THEM.

 

Even while vaccines are rolling out, COVID-19 testing will remain crucial to helping us all return to normal as we begin to engage in everyday life once again. The BinaxNOW COVID-19 Self Test card is identical to the professional-use test card, used since August 2020, and is the most studied and widely available rapid antigen test – allowing schools, employers and communities to utilize rapid testing.

 

Now, with BinaxNOW authorized for over the counter for frequent asymptomatic use, we are making testing directly available for fast results, when and where you need it. You can now access our BinaxNOW test in 3 ways: at your local retailer over the counter self-test, or proctored at-home or from your healthcare professional. This combination will help attack the pandemic on critical fronts – speed, simplicity, affordability, access and reliability.

 

No more lines, no more wait times, no more barriers and no more inconveniences. Answers are now in your hands.



ACCESS THE TEST
CONDUCTING YOUR SELF TEST

Just got home with your BinaxNOW Self Test? Here's what you need to know to conduct your test correctly.

 
BINAXNOW™ COVID-19 ANTIGEN SELF TEST:

In need of rapid results with no barriers or inconveniences? Click here for product information or learn where you can purchase the self test.

 

BinaxNOW™ Ag Card Home Test:

Click here for product information on the test that allows rapid results in the safety and convenience of your home.

 

BinaxNOW™ Ag Card:

For professional use, click here for product information.




RAPID TESTING'S IMPACT
BinaxNOW Ag is now available over-the-counter READ MORE
OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS
BinaxNOW Ag is now available over-the-counter, bringing accessible COVID-19 rapid self-testing to the masses.
BACK ON CAMPUS WITH RAPID TESTS READ MORE
BACK ON CAMPUS WITH RAPID TESTS
Reliable, rapid tests bring students on campus.
FASTER ISOLATION, REDUCE SPREAD THE ROLE OF BINAXNOW IN COMMUNITY TESTING READ MORE
FASTER ISOLATION, REDUCE SPREAD THE ROLE OF BINAXNOW IN COMMUNITY TESTING
Affordability, reliability, accessibility: The impact of BinaxNOW in communities.
For Parents and Schools READ MORE
PARENTS, SCHOOLS: BINAXNOW OFFERS COVID-19 ANSWERS
With the prospect of kids returning to school, we’re here to help.
VIDEO: A DIGITALLY-CONNECTED RAPID TEST AND MOBILE APP WATCH VIDEO
VIDEO: A DIGITALLY-CONNECTED RAPID TEST AND MOBILE APP
Comprehensive testing solution to help you feel more confident about your health.
MORE INFO: YOUR NAVICA APP QUESTIONS ANSWERED HERE READ MORE
MORE INFO: YOUR NAVICA APP QUESTIONS ANSWERED HERE
What is it, where you can get it and other answers to help you get started.
USE THE NAVICA APP

 

 

 

For the professional use and at-home versions of BinaxNOW, you can receive verified tests results to your phone via our NAVICA mobile app.

 

DOWNLOAD THE APP

Get the app before your first test.

Apple Store

Google Play

THE SCIENCE
VIDEO: ATTACKING THIS VIRUS FROM EVERY ANGLE WE CAN PLAY VIDEO
VIDEO: ATTACKING THIS VIRUS FROM EVERY ANGLE WE CAN
BinaxNOW and NAVICA are strong tools to help us get back to daily life.
VIDEO: BINAXNOW CAN HELP  LOWER RISK OF DISEASE SPREAD
VIDEO: BINAXNOW CAN HELP LOWER RISK OF DISEASE SPREAD
Explaining the trade-offs between rapid antigen tests vs. lab-based tests.
VIDEO: KEY TO COVID-19 TEST IS COMMUNICATION OF RESULTS PLAY VIDEO
VIDEO: KEY TO COVID-19 TEST IS COMMUNICATION OF RESULTS
Expert says a test with an app improves efficiency of communicating results.

Connect with Us

The BinaxNOW™ COVID-19 Antigen Self Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection when tested twice over three days with at least 36 hours between tests. This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 15 years or older or adult collected anterior nasal swab samples from individuals aged two years or older.

 

The BinaxNOW COVID-19 Ag 2 Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swab samples from COVID-19 symptomatic individuals tested twice over three days with at least 36 hours between tests within the first seven days of symptom onset.

 

This test is authorized for use with direct anterior nasal (nares) swab samples from individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested twice over three days with at least 36 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

 

The BinaxNOW COVID-19 Ag Card 2 Home Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection when tested twice over three days with at least 36 hours between tests. This test is authorized for non-prescription home use with self-collected observed direct anterior nasal (nares) swab samples from individuals aged 15 years or older or adult collected anterior nasal swab samples from individuals aged two years or older. The BinaxNOW COVID-19 Ag Card 2 Home Test is to be performed only with the supervision of a telehealth proctor.

 

The BinaxNOW COVID-19 Ag tests have not been FDA cleared or approved. They have been authorized by the FDA under an emergency use authorization. The tests have been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

FOR THE LATEST ON LIFE-CHANGING TECHNOLOGY, GET ABBOTT EDGE DELIVERED TO YOUR INBOX

Please Enter Your Email

*Required 

Intended for U.S. residents only. Please review our privacy policy and terms & conditions.

Abbott EDGE Archive: We've brought our past issues together here, with new installments added each month. Thanks for reading.

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website??